Acute Myelomonocytic Leukemia

Search Trials
A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Status:
Recruiting
Last Changed:
Apr 22, 2022
First Changed:
Oct 30, 2020
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
JNJ-74856665AZAVEN
Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
Status:
Active, not recruiting
Last Changed:
Mar 16, 2022
First Changed:
Dec 3, 2010
Disease(s):
Acute Myeloid Leukemia With FLT3/ITD Mutation
Intervention(s):
BiopsyBone Marrow AspirationCytarabineDaunorubicin HydrochlorideLaboratory Biomarker AnalysisQuality-of-Life AssessmentQuestionnaire AdministrationSorafenib Tosylate
Umbilical Cord Blood Transfusion in Consolidation Therapy of Elderly Patients With Acute Myeloid Leukemia
Status:
Recruiting
Last Changed:
Aug 24, 2021
First Changed:
Dec 29, 2020
Disease(s):
Leukemia, Myelomonocytic, Acute
Intervention(s):
umbilical cord blood
Tagraxofusp and Decitabine for the Treatment of Chronic Myelomonocytic Leukemia
Status:
Recruiting
Last Changed:
Mar 7, 2022
First Changed:
Sep 9, 2021
Disease(s):
Chronic Myelomonocytic Leukemia
Intervention(s):
DecitabineTagraxofusp-erzs
Fostamatinib for the Treatment of Lower-risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Who Have Failed Therapy With Hypomethylating Agents
Status:
Recruiting
Last Changed:
Sep 1, 2021
First Changed:
Sep 1, 2021
Disease(s):
Refractory Chronic Myelomonocytic Leukemia
Intervention(s):
Fostamatinib

Connect. Empower. Inspire.